Therapeutic Approach

Archive: June, 2016

Ritter Pharmaceuticals Issued Method of Use Patent for RP-G28

Patent covers methods for treating symptoms associated with lactose intolerance and improving gastrointestinal health LOS ANGELES (June 28, 2016) – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced that it recently has been issued […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD